论文部分内容阅读
Objective:Treatment strategies for recurrent hepatocellular carcinoma(rHCC)are controversial.We used the status of microvascular invasion(MVI)at primary resection as a marker to choose moderate treatment options for rHCC patients with Barcelona Clinic Liv